Okushiwo ucwaningo
Esingakushongokuqiniseka.
Isikhwama se-nicotine esimhlophe siwuhlobo lomkhiqizo olusha, futhi ucwaningo oluzimele ngalo lusakhula. Isifinyezo esingezansi sisekelwe emisebenzini emithathu ebalulekile eshicilelwe ngo-2024 nango-2025: isinqumo sokugunyaza se-U.S. Food and Drug Administration, isitatimende senqubomgomo se-American Heart Association, kanye nokubuyekezwa kocwaningo lwenhliziyo nemithambo yegazi okuhlobene ne-Yale. Awukho kule mithombo ophetha ngokuthi izikhwama ze-nicotine ziphephile. Lokho ekufakazelayo ndawonye kuqondile kakhulu.
Okutholakele 1
Ukugunyaza kwe-FDA: izinto ezinobuthi ezimbalwa kunogwayi obhenywayo.
Mhla zingu-16 kuJanuwari 2025, i-FDA yagunyaza imikhiqizo engamashumi amabili yezikhwama ze-nicotine, okuwuhla lwe-ZYN lwe-Swedish Match, ngohlelo lwayo lwe-Premarket Tobacco Product Application. Yaba yizikhwama ze-nicotine zokuqala ukuthola imvume yokumaketha kulesi sikhungo. I-FDA yaphawula ukuthi le mikhiqizo iqukethe amazinga aphansi kakhulu ezithako eziyingozi uma kuqhathaniswa nosikilidi, nokuthi ubufakazi babonisa ukuthi ingxenye ephawulekayo yababhemi abadala abayisebenzisa bayeka ngokuphelele osikilidi. Lesi sikhungo sacacisa ukuthi ukugunyaza akusikho ukuvunywa, futhi akusho ukuthi imikhiqizo iphephile.
U.S. FDA, Marketing Granted Order yezikhwama ze-nicotine ze-ZYN, Januwari 2025
Okutholakele 2
I-American Heart Association: izikhwama azikhululekile ezingozini.
NgoDisemba 2024, i-American Heart Association yashicilela isitatimende senqubomgomo ephephabhukwini layo i-Circulation mayelana nemikhiqizo ye-nicotine yomlomo engabhenywa, kuhlanganise nezikhwama ze-nicotine. Siphetha ngokuthi imiphumela yesikhathi eside yale mikhiqizo enhliziyweni nasemithanjeni yegazi ayikaziwa, ukuthi akucacile ukuthi iyabasiza yini abantu ukuyeka ukubhema, nokuthi ukunambitheka, amaphakethe anemibala egqamile nokumaketha ezinkundleni zokuxhumana kungaheha intsha. I-AHA ifuna ucwaningo olwengeziwe, ukulawulwa okuqinile kokwakhiwa nokumakethwa kwemikhiqizo, amalebula axwayisayo kanye nentela, futhi icela odokotela ukuthi bahlole zonke iziguli ukuthi zisebenzisa i-nicotine yini, futhi bathembele ekwelashweni okufakazelwe uma besiza abantu ukuyeka.
I-American Heart Association, isitatimende senqubomgomo ku-Circulation, Disemba 2024
Okutholakele 3
Ukubuyekezwa kwe-Yale New Haven Health: izikhwama ezinamandla aphezulu zikhuphula izinkomba zenhliziyo nemithambo yegazi.
Ukubuyekezwa okufushane okushicilelwe ku-Frontiers in Public Health ngoNovemba 2025 ngodokotela base-Yale New Haven Health kwahlola ubufakazi mayelana nezikhwama ze-nicotine nengozi yenhliziyo nemithambo yegazi, kugxilwe entsheni. Kukhomba ucwaningo lwasemtholampilo lwango-2024 kubabhemi abadala, lapho izikhwama ezingu-20 mg nezingu-30 mg zakhuphula ukushaya kwenhliziyo nokuqina kwemithambo yegazi ngokuya ngomthamo ngemva kokusetshenziswa kanye, futhi lapho isikhwama esingu-30 mg sakhipha i-nicotine eningi kunosikilidi. Ababhali baphawula ukuthi ubufakazi obuqondile besikhathi eside busengebuncane, nokuthi ukusebenzisa phakathi kwentsha esakhula kuyanda, futhi bafuna ucwaningo olwengeziwe, imikhawulo emazingeni e-nicotine, ekunambithekeni nasezimangalweni zokumaketha, nokuthi iziguli ezisencane zihlolwe mayelana nayo yonke imikhiqizo ye-nicotine.
Abid et al., Frontiers in Public Health, Novemba 2025 (Yale New Haven Health)
Ukuma kwethu
Ukuma kwethu: kwabantu abadala asebevele besebenzisa i-nicotine.
Awukho kule mithombo othi izikhwama ze-nicotine ziphephile, futhi awukho oyincoma kubantu abangayisebenzisi kakade i-nicotine. Ukuma kwe-Swidi AB kususela kulokho. Izikhwama aziwona umkhiqizo wezokwelapha, futhi azigunyaziwe njengosizo lokuyeka ukubhema. Zenzelwe abantu abadala asebevele besebenzisa i-nicotine. Akufanele zisetshenziswe yinoma ngubani ongaphansi kweminyaka engu-18 (iminyaka evunyelwe ngumthetho lapho ukhona), ngabesifazane abakhulelwe noma abancelisayo, ngabantu abangasebenzisi i-nicotine njengamanje, noma ngabantu abanesifo senhliziyo noma semithambo yegazi ngaphandle kokuthi baqale bakhulume nodokotela. Isinqumo se-FDA sisebenza kuphela emikhiqizweni ethile ye-ZYN eyagunyazwa mhla zingu-16 kuJanuwari 2025. Akusikho ukuvunywa noma ukuqinisekiswa kokuphepha, futhi asifinyeleli ku-Swidi AB noma emikhiqizweni ye-Kurbits i-Avant ne-ViD esiyisabalalisayo.
I-Swidi AB, ngokusekelwe esinqumweni se-FDA (Januwari 2025), esitatimendeni senqubomgomo se-AHA (Disemba 2024) nasekubuyekezweni kwe-Yale New Haven Health (Novemba 2025)